BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of purchasers of the securities of InVivo Therapeutics Holdings Corp. (“InVivo” or the “Company”) (OTC:NVIV) between April 5, 2013 and August 26, 2013, inclusive (the “Class Period”).
InVivo develops biomaterial technologies for the treatment of spinal cord injuries and hydrogels for therapeutics delivery. The Complaint alleges that defendants misrepresented and/or failed to disclose that the Company’s clinical study for its biopolymer scaffolding to treat acute spinal cord injuries would not be completed with all data submitted to the FDA by the end of 2014, and the Company did not anticipate completing this clinical study until late 2015. As a result, the Company’s statements about its clinical study timeline for biopolymer scaffolding to treat acute spinal cord injuries were materially false and misleading and/or lacked a reasonable basis.
If you are a member of the Class described above, you have until October 6, 2014, to move the Court to serve as lead plaintiff, if you meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at 215-638-4847, Toll-Free at 888-638-4847, or by email to firstname.lastname@example.org, or visit our website at http://www.howardsmithlaw.com.